Longaeva Partners »

Rhythm Pharmaceuticals shares owned by Longaeva Partners

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 110k 111.03

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Rhythm Pharmaceuticals

RA Capital Management
BlackRock
Baker Bros. Advisors
PRIMECAP Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Jpmorgan Chase & Co
Perceptive Advisors
State Street Corporation
Westfield Capital Management Company
Goldman Sachs Group
Federated Investors
Polar Capital Holdings
T. Rowe Price Associates
Geode Capital Management

View all funds holding Rhythm Pharmaceuticals